These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 28373989)
21. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C; J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457 [TBL] [Abstract][Full Text] [Related]
22. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R; Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079 [TBL] [Abstract][Full Text] [Related]
23. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents. Wu XA; Xie G; Li XQ; Wu HT; Wang X Clin Chim Acta; 2018 Apr; 479():20-24. PubMed ID: 29305846 [TBL] [Abstract][Full Text] [Related]
24. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555 [TBL] [Abstract][Full Text] [Related]
25. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry. Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844 [TBL] [Abstract][Full Text] [Related]
26. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents. Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J; J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863 [TBL] [Abstract][Full Text] [Related]
27. Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice. Appleby CE; Khattar RS; Morgan K; Clarke B; Curzen N; Neyses L; Fath-Ordoubadi F EuroIntervention; 2011 Jan; 6(6):748-53. PubMed ID: 21205600 [TBL] [Abstract][Full Text] [Related]
28. Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up. Freixa X; Almasood AS; Khan SQ; Wainstein R; Osherov A; Mackie K; Seidelin PH; Džavík V Catheter Cardiovasc Interv; 2012 Mar; 79(4):559-65. PubMed ID: 21567881 [TBL] [Abstract][Full Text] [Related]
29. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison. Iofina E; Radke PW; Skurzewski P; Haager PK; Blindt R; Koch KC; Hanrath P; vom Dahl J; Hoffmann R Heart; 2005 Dec; 91(12):1584-9. PubMed ID: 15797938 [TBL] [Abstract][Full Text] [Related]
30. Late catch-up phenomenon associated with stent fracture after sirolimus-eluting stent implantation: incidence and outcome. Serikawa T; Kawasaki T; Koga H; Orita Y; Ikeda S; Goto Y; Shintani Y; Kajiwara M; Tanaka H; Fukuyama T; Koga N J Interv Cardiol; 2011 Apr; 24(2):165-71. PubMed ID: 21198850 [TBL] [Abstract][Full Text] [Related]
31. A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. Liu X; Doi H; Maehara A; Mintz GS; Costa Jde R; Sano K; Weisz G; Dangas GD; Lansky AJ; Kreps EM; Collins M; Fahy M; Stone GW; Moses JW; Leon MB; Mehran R JACC Cardiovasc Interv; 2009 May; 2(5):428-34. PubMed ID: 19463466 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms of balloon angioplasty and repeat stenting in patients with drug-eluting in-stent restenosis. Alfonso F; Sandoval J; Pérez-Vizcayno MJ; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Ibáñez B; Núñez-Gil I; Rivero F; Escaned J; Fernández-Ortíz A; Macaya C Int J Cardiol; 2015 Jan; 178():213-20. PubMed ID: 25464257 [TBL] [Abstract][Full Text] [Related]
33. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation. Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559 [TBL] [Abstract][Full Text] [Related]
34. Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9. Katsaros KM; Kastl SP; Zorn G; Maurer G; Wojta J; Huber K; Christ G; Speidl WS JACC Cardiovasc Interv; 2010 Jan; 3(1):90-7. PubMed ID: 20129576 [TBL] [Abstract][Full Text] [Related]
35. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis. Almalla M; Schröder J; Pross V; Marx N; Hoffmann R Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557 [TBL] [Abstract][Full Text] [Related]
36. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice. Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991 [TBL] [Abstract][Full Text] [Related]
37. Comparison between drug-eluting stents and beta-radiation for the treatment of diffuse in-stent restenosis: clinical and angiographic outcomes. Zavalloni D; Belli G; Rossi ML; Scatturin M; Morenghi E; Catalano G; Tosi G; Gasparini GL; Pagnotta P; Presbitero P Am Heart J; 2006 Nov; 152(5):908.e1-7. PubMed ID: 17070155 [TBL] [Abstract][Full Text] [Related]
38. A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis. Li JJ; Xu B; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL Chin Med J (Engl); 2006 Jul; 119(13):1059-64. PubMed ID: 16834923 [TBL] [Abstract][Full Text] [Related]
39. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease. Xu X; Pandit RU; Han L; Li Y; Guo X Angiology; 2019 Oct; 70(9):853-859. PubMed ID: 31167539 [TBL] [Abstract][Full Text] [Related]
40. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]